Decahydro-1H-indenoquinolinone and decahydro3H-cyclopentaphenanthridinone CYP17 inhibitors

Details for Australian Patent Application No. 2009320250 (hide)

Owner BioMarin Pharmaceutical Inc.

Inventors Chu, Daniel; Myers, Peter L.; Wang, Bing

Agent Wrays

Pub. Number AU-A-2009320250

PCT Pub. Number WO2010/062506

Priority 61/108,966 28.10.08 US

Filing date 21 October 2009

Wipo publication date 3 June 2010

International Classifications

C07D 215/04 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61P 35/00 (2006.01) Antineoplastic agents

C07D 215/02 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 311/02 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 311/04 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/062506 Priority application(s): WO2010/062506

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009320251-Disubstituted phthalazine Hedgehog pathway antagonists

2009320248-Apparatus and method for activation of components of an energized ophthalmic lens